Medical Oncology

Prof. Dr. Ömer Fatih Ölmez

Doctor and researcher Acıbadem Maslak Hastanesi İstanbul
Breast NeoplasmsLung NeoplasmsStomach NeoplasmsColorectal NeoplasmsCarcinoma, Non-Small-Cell LungUrinary Bladder NeoplasmsCarcinoma, Transitional CellAdenocarcinomaOvarian NeoplasmsRectal NeoplasmsUrologic NeoplasmsBrain NeoplasmsCarcinoma, Ovarian EpithelialNeoplasmsColonic Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 17 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Lung Neoplasms 11 publications
  • Stomach Neoplasms 8 publications
  • Colorectal Neoplasms 7 publications
  • Carcinoma, Non-Small-Cell Lung 6 publications
  • Urinary Bladder Neoplasms 6 publications
  • Carcinoma, Transitional Cell 5 publications
  • Adenocarcinoma 4 publications
  • Ovarian Neoplasms 3 publications
  • Rectal Neoplasms 3 publications
  • Urologic Neoplasms 3 publications
  • Brain Neoplasms 3 publications
  • Carcinoma, Ovarian Epithelial 2 publications
  • Neoplasms 2 publications
  • Colonic Neoplasms 2 publications

CV

Education and experience

From source

Experience

  • 2025Acıbadem Sağlık Grubuacibadem.com.tr
  • 2025Acıbadem Üniversitesi / Tıbbi Onkoloji Bilim Dalı / Halenacibadem.com.tr
  • 2014 - 2025İstanbul Medipol Üniversitesi / Tıbbi Onkoloji Bilim Dalıacibadem.com.tr
  • 2012 - 2014Bursa Ali Osman Sönmez Onkoloji Hastanesi / Tıbbi Onkoloji Bilim Dalıacibadem.com.tr
  • 2009 - 2012Uludağ Üniversitesi Tıp Fakültesi / Tıbbi Onkoloji Bilim Dalıacibadem.com.tr
  • 2004 - 2009Uludağ Üniversitesi Tıp Fakültesi / İç Hastalıkları Anabilim Dalıacibadem.com.tr
  • 2001 - 200319 Mayıs Üniversitesi Tıp Fakültesi / Radyodiagnostik Anabilim Dalıacibadem.com.tr

Education

  • 2019Profesörlük / Tıbbi Onkoloji Bilim Dalı, Digeracibadem.com.tr
  • 2014Doçentlik / Tıbbi Onkoloji Bilim Dalı, Digeracibadem.com.tr
  • 2012Uludağ Üniversitesi Tıp Fakültesi, Tıbbi Onkoloji, Üst Uzmanlıkacibadem.com.tr
  • 2009Uludağ Üniversitesi Tıp Fakültesi, İç Hastalıkları, Uzmanlıkacibadem.com.tr
  • 200319 Mayıs Üniversitesi Tıp Fakültesi / Radyoloji, Digeracibadem.com.tr
  • 2001Ondokuzmayıs Üniversitesi Tıp Fakültesi, Üniversiteacibadem.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologyacibadem.com.trFrom source
  • InstitutionAcıbadem Maslak Hastanesiacibadem.com.trFrom source
  • Area of workBreast NeoplasmsExtracted from 17 publications · Model version —From source
  • Publications164 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0001-7934-7039ORCIDFrom source
  • Last synchronised4 November 2026 21:11https://www.acibadem.com.tr/doktor/omer-fatih-olmez/acibadem.com.tr

Scientific work

Publications on Breast Neoplasms

164 publications

  1. Real-World Outcomes of 177Lu-PSMA-617 Radioligand Therapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer

    Cerrahpasa Medical Journal, 2026

    DOI 10.5152/cjm.2026.26082 Open-access full textSource: OpenAlex

  2. Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study

    Cancers, 2026

    DOI 10.3390/cancers18121979 PMID 42352512 Open-access full textSource: OpenAlex

  3. Resection and pathological response after neoadjuvant nivolumab plus chemotherapy for lung cancer in a Turkish Oncology Group (TOG) real-world study

    Research Square, 2026

    DOI 10.21203/rs.3.rs-11204389/v1 Open-access full textSource: OpenAlex

  4. Predictive and Prognostic Value of Androgen Receptor Expression Across All Molecular Subtypes in Patients with Breast Cancer Who Received Neoadjuvant-Treatment: Single-Center Retrospective Analysis

    Breast Cancer Targets and Therapy, 2026

    DOI 10.2147/bctt.s647399 PMID 42936308 Open-access full textSource: OpenAlex

  5. Real-world Efficacy and Safety of Trastuzumab Deruxtecan in HER2-positive Metastatic Breast Cancer: A Multicenter Retrospective Study from Türkiye

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2026-1-1 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  6. Unveiling the Uncommon: A Comprehensive Review and Case Report on Targeting Rare MET Fusions in NSCLC

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2025-7-10 Open-access full textSource: OpenAlex

  7. Investigation of Predictive and Prognostic Factors in Metastatic Renal Cell Carcinoma (mRCC) Patients Receiving First-line Treatment: A Retrospective Single-center Experience

    Bagcilar Medical Bulletin, 2026

    DOI 10.4274/bmb.galenos.2026.78942 Open-access full textSource: OpenAlex

  8. Preimplantation genetic testing (PGT-M) awareness in BRCA-positive individuals in Türkiye: a dual physician–patient survey

    Scientific Reports, 2026

    DOI 10.1038/s41598-026-61177-3 PMID 42414499 Open-access full textSource: OpenAlex

  9. Investigating the feasibility of cascade genetic testing for BRCA1/2 in Türkiye: physicians' practices, barriers, and solutions

    European Journal of Cancer Care, 2026

    DOI 10.48130/ejcc-0026-0010 Source: OpenAlex

  10. Clinicopathologic Features of NRG1 Fusion‐Positive Non‐Small Cell Lung Cancer

    Genes, Chromosomes and Cancer, 2026

    DOI 10.1002/gcc.70170 PMID 42706502 Open-access full textSource: ORCID

View all 164 publications